Integrating traditional Chinese medicine with pancreatic cancer organoids: Bibliometric insights and translational perspectives

doi:10.4251/wjgo.123966

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(8)

(7)

(1)

(0)

(30)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Scientometrics

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Oct 15, 2026; 18(10): 123966
Published online Oct 15, 2026. doi: 10.4251/wjgo.123966

Full Size Figure Download Figure

Figure 14 Summary diagram of the target sites of traditional Chinese medicine compounds in pancreatic ductal adenocarcinoma-related signaling pathways. PDAC: Pancreatic ductal adenocarcinoma; TME: Tumor microenvironment; VEGF: Vascular endothelial growth factor; TGF-β: Transforming growth factor-beta; 3D: Three-dimensional; BRAF: B-Raf proto-oncogene, serine/threonine kinase; MEK: Mitogen-activated protein kinase kinase; ERK: Extracellular regulated protein kinases; PI3K: Phosphatidylinositol 3-kinase; Akt: Protein kinase B; NF-κB: Nuclear factor kappa B; 2D: Two-dimensional; EMT: Epithelial-mesenchymal transition; STAT3: Signal transducer and activator of transcription 3; PDOs: Patient-derived organoids; TCMs: Traditional Chinese medicine.

Citation: Chen QZ, Chi X, Pan JH, Cheng QZ, Guo YJ, Liu YX, Yu L, Feng WK. Integrating traditional Chinese medicine with pancreatic cancer organoids: Bibliometric insights and translational perspectives. World J Gastrointest Oncol 2026; 18(10): 123966
URL: https://www.wjgnet.com/1948-5204/full/v18/i10/123966.htm
DOI: https://dx.doi.org/10.4251/wjgo.123966

Chen QZ, Chi X, Pan JH, Cheng QZ, Guo YJ, Liu YX, Yu L, Feng WK. Integrating traditional Chinese medicine with pancreatic cancer organoids: Bibliometric insights and translational perspectives. World J Gastrointest Oncol 2026; 18(10): 123966 [DOI: 10.4251/wjgo.123966]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.